Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 33, 162-167
Abstract
No abstract availableKeywords
Funding Information
- Dagmar Marshalls Fond
- Axel Muusfeldts Fond
This publication has 29 references indexed in Scilit:
- Mechanisms for lesion localization in neuromyelitis optica spectrum disordersCurrent Opinion in Neurology, 2018
- Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation studyDevelopmental Medicine & Child Neurology, 2018
- MOG encephalomyelitis: international recommendations on diagnosis and antibody testingJournal of Neuroinflammation, 2018
- Pediatric acquired demyelinating syndromes: a nationwide validation study of the Danish National Patient RegisterClinical Epidemiology, 2018
- Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseJAMA Neurology, 2018
- Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndromeNeurology, 2017
- Diagnostic algorithm for relapsing acquired demyelinating syndromes in childrenNeurology, 2017
- Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977–2015: A nationwide population-based incidence studyMultiple Sclerosis Journal, 2017
- Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in childrenNeurology Neuroimmunology & Neuroinflammation, 2015
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008